{
    "clinical_study": {
        "@rank": "3297", 
        "arm_group": [
            {
                "arm_group_label": "Endoscopy Barrett's", 
                "description": "Patients undergoing clinically indicated upper endoscopy will be invited to participate. Patients who are known to have Barrett's Esophagus as well as patient who do not will be approached for enrollment"
            }, 
            {
                "arm_group_label": "Endoscopy control", 
                "description": "Patients undergoing clinically indicated upper endoscopy will be invited to participate. Patients who are known to have Barrett's Esophagus as well as patient who do not will be approached for enrollment"
            }
        ], 
        "biospec_descr": {
            "textblock": "Tissue and cytology brushes will be stored for the duration of the study"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "This study is to identify potential markers from esophageal biopsies and brush cytology for\n      feasibility of use in stool specimens for detection of Barretts Esophagus."
        }, 
        "brief_title": "Gene Methylation in the Diagnosis of Barrett's Esophagus: Identification of Candidate Diagnostic Markers", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Barrett's Esophagus", 
        "condition_browse": {
            "mesh_term": "Barrett Esophagus"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Exclusion criteria for cases and controls:\n\n        Patients with history of esophagectomy or mucosal ablation, gastric fundoplication or\n        other gastric surgery, or known non-Barrett's esophageal pathology (e.g. eosinophilic\n        esophagitis or achalasia) will be excluded. Patients with prior history of colon polyps or\n        colon/esophageal/gastric/pancreatic carcinoma (unless had negative colonoscopy within 2\n        years to clear polyps).\n\n        Control patients without endoscopic evidence of Barrett's will be frequency matched by age\n        (\u00b1 5 years) and gender (similar distribution) to cases. To ensure similar age and gender\n        distribution between cases and controls, monitoring of recruited cases and controls age\n        and gender distribution will be performed every two weeks. Data on height, weight, smoking\n        history, medications (NSAIDS, PPIs) and indications (as well as findings on endoscopy) for\n        endoscopy will be abstracted from medical records.  All participants will be >18 years of\n        age and will provide informed consent.\n\n        Exclusion Criteria:\n\n          -  Exclusion criteria for cases:\n\n        Patients with history of esophagectomy or mucosal ablation, gastric fundoplication or\n        other gastric surgery, or known non-Barrett's esophageal pathology (e.g. eosinophilic\n        esophagitis or achalasia) will be excluded. Patients with prior history of colon polyps or\n        colon/gastric/pancreatic carcinoma (unless had negative colonoscopy within 2 years to\n        clear polyps)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patient scheduled for clinically indicated upper endoscopy will be approached to\n        participate in this study"
            }
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 3, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02066701", 
            "org_study_id": "12-001575"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Barrett's esophagus", 
        "lastchanged_date": "February 17, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Rochester", 
                    "country": "United States", 
                    "state": "Minnesota", 
                    "zip": "55905"
                }, 
                "name": "Mayo Clinic"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "official_title": "Utility of Aberrant Gene Methylation in the Diagnosis of Barrett's Esophagus: Identification of Candidate Diagnostic Markers", 
        "overall_official": {
            "affiliation": "Mayo Clinic", 
            "last_name": "Prasad G Iyer, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "we will plan to identify the best markers from highly selected marker candidates to differentiate between subjects who have BE and those who do not have BE.", 
            "measure": "to determine if assay of aberrantly methylated gene markers can discriminate Barrett's Esophagus tissue from esophageal squamous and gastric cardia tissue.", 
            "safety_issue": "No", 
            "time_frame": "1 day"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02066701"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Mayo Clinic", 
            "investigator_full_name": "Prasad G. Iyer", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Assess the ability of stool markers to distinguish between subjects who have BE and those who do not.", 
            "measure": "Assess the accuracy of candidate markers in stool for detection of Barrett's Esophagus", 
            "safety_issue": "No", 
            "time_frame": "One day"
        }, 
        "source": "Mayo Clinic", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mayo Clinic", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}